Skip to main content


Showing posts with the label Alzheimer's disease

Breakthrough or Breakdown? Aducanumab’s Approval by the FDA with Comments from Neurologist Dr. Allan Levey

Aduhelm Puts Patients At The Helm, But At What Cost?

April International Neuroethics Society Webinar: Brain Data Governance and Neuroethics  

Neuroethics, Privacy, and Data Governance: Advocating for Identifying Root Challenges Before Going to Tactics

Alzheimer’s Disease and the FDA: Two Things To Watch

The Emerging Workplace Dilemma: Employment & the Alzheimer’s Disease Continuum

Emory Neuroethics on Facebook